GENSIGHT BIOLOGICS S.A. (EPA:SIGHT)

PRESS RELEASE

published on 09/27/2024 at 11:24, 1 year 5 months ago

HALF-YEAR_FINANCIAL_REPORT_JUNE_2024
BRIEF

published on 09/23/2024 at 19:41, 1 year 6 months ago

GenSight Biologics Reports Interim Financial Results for H1 2024

Financial Results Cash Management LUMEVOQ® Early Access Program R&D Expenses
BRIEF

published on 09/23/2024 at 19:41, 1 year 6 months ago

GenSight Biologics publie ses résultats financiers intermédiaires pour le premier semestre 2024

Résultats Financiers LUMEVOQ® Programme D'accès Anticipé Dépenses De Recherche Et Développement Gestion De Trésorerie
PRESS RELEASE

published on 09/23/2024 at 19:36, 1 year 6 months ago

Inside Information / News release on accounts, results
GenSight Biologics reports interim financial results for the first half of 2024, highlighting optimized cash management, extension of cash runway, and upcoming LUMEVOQ® drug product release

Cash Management GenSight Biologics Interim Financial Results LUMEVOQ® Drug Product Release
PRESS RELEASE

published on 09/23/2024 at 19:36, 1 year 6 months ago

Informations privilégiées / Communiqué sur comptes, résultats
GenSight Biologics publie ses résultats financiers du premier semestre 2024 avec une réduction des dépenses opérationnelles de 60% et l'extension de son horizon de trésorerie. Nouveau Directeur Administratif et Financier nommé

Résultats Financiers GenSight Biologics Directeur Administratif Et Financier Dépenses Opérationnelles Horizon De Trésorerie
BRIEF

published on 09/17/2024 at 14:45, 1 year 6 months ago

Goldman Sachs vend ses actions GENSIGHT BIOLOGICS S.A.

Euronext Paris Franchissement De Seuils Goldman Sachs Cession D'actions GenSight Biologics
BRIEF

published on 09/17/2024 at 14:45, 1 year 6 months ago

Goldman Sachs sells its GENSIGHT BIOLOGICS SA shares

Euronext Paris Goldman Sachs Crossing Thresholds Transfer Of Shares GenSight Biologics
PRESS RELEASE

published on 09/17/2024 at 14:40, 1 year 6 months ago

Franchissement de seuils
Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. concernant GENSIGHT BIOLOGICS S.A. sur Euronext Paris

Euronext Paris Déclaration The Goldman Sachs Group Franchissement De Seuils GenSight Biologics
BRIEF

published on 07/23/2024 at 07:35, 1 year 8 months ago

GenSight Biologics Reports Financial Position and Business Progress

Gene Therapy Financial Update GenSight Biologics LUMEVOQ Early Access Program
BRIEF

published on 07/23/2024 at 07:35, 1 year 8 months ago

GenSight Biologics présente sa situation financière et ses progrès commerciaux

Thérapie Génique Mise À Jour Financière Produits Biologiques GenSight LUMEVOQ Programme D'accès Anticipé

Published on 03/24/2026 at 07:00, 31 minutes ago

Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 31 minutes ago

Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/24/2026 at 00:55, 6 hours 36 minutes ago

BTU Closes Oversubscribed Financing
Published on 03/23/2026 at 22:40, 8 hours 51 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 9 hours 1 minute ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp

View all ACCESSWIRE

Published on 03/24/2026 at 07:23, 7 minutes ago

INDUS confirms a solid financial year 2025 – Proposed dividend of EUR 1.30 exceeds previous year
Published on 03/24/2026 at 07:00, 30 minutes ago

After strong fourth quarter, INFICON closes 2025 at record sales level
Published on 03/24/2026 at 07:00, 30 minutes ago

Curatis: Double-digit revenue growth in 2025 and major milestones for corticorelin achieved
Published on 03/24/2026 at 07:00, 30 minutes ago

MCH Group Reports Profitability Improvement in 2025
Published on 03/24/2026 at 07:00, 30 minutes ago

MCH Group améliore sa rentabilité en 2025

View all EQS

Published on 03/23/2026 at 19:08, 12 hours 23 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 12 hours 23 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 12 hours 53 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 13 hours 46 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 13 hours 46 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE

News